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A B S T R A C T
The aim of this study was to investigate, based on routinely collected data, the scope of family doctors work in the field
of men’s health. Based on the Croatian Health Service Yearbook in the period from 1995 to 2012, we collected the morbid-
ity data related to male urogenital disorders. The total number of urogenital disorders almost doubled, but the number of
diagnoses related to the men increased fourfold, mostly among the oldest patients. The number of prostate hyperplasia
increased fivefold, again among the oldest people. The morbidity from other male-specific diseases increased threefold,
mostly in the age group 7–19 years. In spite of the increase in the number of newly diagnosed cases of prostate cancer, the
percentage of the deaths stabilized after 2001. Men’s health problems are frequent sees and with an upward trend. We are
not sure if this means deterioration of men’s health, or just indicates the problem of »overdiagnosis«.
Key words: men’s health, prostate hypertrophy, prostate cancer, family medicine, Croatia
Introduction
Women’s health has long since been recognized as a
public health priority, most likely due to the reproductive
role women play in a country’s demographic rejuvena-
tion. Unfortunately, men’s health on the other hand, is
not seen as a priority, even though there are many indica-
tors of serious consequences of diseases and inequality
when it comes to the male gender1,2. The increase in the
number of cases of male sterility and the key role men
have in safeguarding the health of children and women
may incite interest3,4. Unlike the comprehensive approach
to promoting women’s health, strategic documents per-
taining to promoting men’s health are only just in the
process of being defined in even the most developed
countries, whereas they are rarely a subject of concern in
undeveloped ones5,6.
To the best of our knowledge, there has been no sys-
tematic discussion of men’s health in family medicine
(FM). Furthermore, there is more primary care physi-
cians (PCPs) involved in promoting women’s health: gy-
necologists, family doctors (FDs) and visiting nurses. On
the other hand, FDs are the only PCPs involved in treat-
ing the adult population including the male gender, but
not even then from the male aspect. This prompted us to
investigate what it actually is that FDs routinely do in
order to promote men’s health. The aim was to investi-
gate the indicators of FDs’ work in the field of men’s
health, based on the routinely collected data. The ob-
tained results could serve as the basis for defining a
strategy how to promote men’s health on the level of FM.
Materials and Methods
Croatian Health Service Yearbook, Croatian National
Institute of Public Health, from 1995 to 2012, served as
the basis for collecting data7. The International Classifi-
cation of Diseases (ICD-10) was used in order to register
morbidity. Morbidity has been registered as the groups of
diseases, whereas morbidity within an individual group
has been registered as a separate disease and, in some
cases, as a group of diseases. Diseases of male gender or-
gans were registered under code group N (diseases of the
genitourinary system) in the yearbook. Prostatic hyper-
trophy was registered separately (N40). All other dis-
eases of male sex organs (N41-N51) were presented as
one sub-group, comprising all other prostate diseases,
diseases of the testicles and seminal duct, penis diseases,
all other inflammatory disorders not classified elsewhe-
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re, as well as physically-caused impotence and male in-
fertility. Although prostate cancer has not been classified
as a separate morbidity category, the data can be found in
a special section of the yearbook, in the malignant dis-
eases registry.
Chronic diseases morbidity is recorded by recording
patient’s first visit to a family practice in a calendar year
as morbidity. All the following visits are not recorded as
morbidity. Morbidity in chronic patients, in our case suf-
fering from prostatic hyperplasia (N40) denotes the
number of patients suffering from the disease. Somehow,
it indicates the prevalence of the disease in the given pop-
ulation, the population in our case being patients who
visited family practices during that year. In the case of
acute diseases, the first visit to a doctor’s office is re-
corded as morbidity, while follow-up visits remain unre-
corded. It needs to be noted that in case of acute diseases
the end of treatment must be recorded. Every patient
visit for the same disease afterwards is recorded as a new
case of morbidity8. Therefore, in cases of the acute dis-
eases, it is rather the incidence not the prevalence rate.
Since 2008, when the entire system of primary health
care was computerized, morbidity has been automati-
cally recorded on the same way for both acute and
chronic diseases.
Data were collected on total morbidity in all code
group N, and separately on prostate hypertrophy (N40)
and other diseases of male sex organs (N41-N51). The
morbidity data in relation to the patients’ age were col-
lected in the way they are presented at the yearbooks:
0–6 years, 7–19 years, 20–64 years and over 65 years.
There were also data collected on morbidity of diseases of
female sex organs recorded in FM for the purpose of com-
parison. Additionally, data were collected on the inci-
dence rate of prostate cancer and the number of deaths,
while calculating the percentage of the death every year
with regard to the number of newly diagnosed diseases in
that calendar year.
The collected data were analysed using Microsoft Of-
fice (Excel) software. The results are presented in the
form of frequency, and the trends are displayed graphi-
cally as line charts.
Results
According to the yearbooks urogenital diseases were
recorded frequently in FM. The trend was relatively sta-
ble. In 1995 they were the fourth, and in 2012 the fifth
most common diseases group7.
In the time period under observation, the total num-
ber of urogenital diseases almost doubled, the number of
diseases specific to the male gender increased 3.9 times
with 38,064 diagnoses recorded in 1995, and 150,071 re-
corded in 2012 (Figure 1).
There was an increase in the share of male diseases in
total urogenital morbidity, going from 9.8% recorded in
1995 to 20.4% in 2012. At the same time there has been a
decrease in share of female gender diseases, from 23.2%
in 1995 down to 17.7% in 2012 (Figure 2).
During observed period, the number of diagnoses of
prostatic hypertrophy increased in 4.8 times, from 20,804
diagnoses in 1995 to 99,376 diagnoses recorded in 2012.
The biggest increase was noted in people aged 65 and
older (5.5 times) (Figure 3).
The morbidity from other males’ diseases (N41-N51)
tripled, from 17,260 diagnoses recorded in 1995, up to
50,693 diagnoses in 2012. The number of diagnoses in
the 7–19 years’ group increased 4.6 times (Figure 4).
On the Table 1, the incidence of prostate cancer was
displayed, as well as the number and percentage of the
deaths per 100 000 citizens in Croatia, from 1995 to
2012.





























































Fig. 1. Trends in total number of urogenital and male organs













































Fig. 2. The shares of the diseases related to the male and female
gender (shown in %) in the total morbidity of urogenital diseases
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Fig. 3. Morbidity trends in prostate hypertrophy (N40) and struc-
ture of morbidity in relation to the men’s’ age recorded in family
medicine in Croatia, 1995–2012.
During the period under observation, the number of
newly diagnosed prostate cancer cases increased for more
than three times. There was also an increase in the num-
ber of patients’ dying from prostate cancer. In spite of the
increase in the number of newly diagnosed cases of pros-
tate cancer, the percentage of the deaths stabilized after
2001 and has since been in the around of 40%.
Discussion
Results of the research indicate that urinogenital dis-
eases are frequently present in FM; in 1995 they were
the fourth, and in 2012 the fifth most common diseases.
However, the total morbidity of the diseases of the uri-
nary tract almost doubled, and the number of cases of
diseases specific to the male gender quadrupled during
the observed period. Most patients were middle aged,
which is understandable given that they are the most nu-
merous group of patients in total populations. An in-
crease was noted in all age groups; 2.4 times in ages 7–19,
and 2.7 times in patients aged 65 and older. The explana-
tion that the rising morbidity, both total and of diseases
of the male sex organs, is due to people being four times
sicker is not likely. It is far more probable that it is a mat-
ter of an increased number of established diagnoses,
most likely as a result of patients and physicians being
more aware of the gravity of these diseases on the one
hand, and the lowering of diagnostic criteria on the other.
The number of diagnoses of prostatic hypertrophy
grew 4.8 times in the observational period, with the big-
gest increase recorded among people aged 65 and older
(5.5 times), which is understandable given that it is a dis-
ease typical for older male population. Nevertheless,
there has also been a rise among middle aged patients
(3.8 times). The availability and habit of using the I-PSS
questionnaire as a screening test, digital rectal examina-
tion, urine analysis and ultrasound allow us to easily di-
agnose hyperplasia9. The starting treatment with an alpha
blocker as the first medicine in conservative treatment of
benign prostatic hypertrophy also falls under the scope
of FDs’ work, and could be the reason why this diagnosis
is given more often. Whether it is a matter of overdiagno-
sis is a subject that needs to be explored.
The total morbidity of other diseases of male sex or-
gans (N41-N51) has tripled, while it has gone up 4.6
times in the 7–19 age groups. It is probably a matter of
an increase in the number of diagnoses due to the raised
awareness of the patients themselves who visit their phy-
sicians more often. This is particularly notable among
patients aged 7 to 19 who visited the doctor significantly
more often for other genital diseases, including other in-
flammatory and sexually transmitted diseases. Bigger
sexual freedom, failure to use prophylactics and aware-
ness of the importance of seeking doctor’s advice proba-
bly caused the increase in diagnoses. Certain anomalies
(phimosis, paraphimosis, varicocele) are noticed and dealt
with at that age. Inflammatory conditions of the prostate
increase in number in middle age, when sexual problems
and problems to do with male infertility stop being ta-
boos in the FD’s office. There has been a rise in aware-
ness of male infertility being related to urogenital infec-
tions and concern with offspring10. Patients also seek
help for sexual dysfunction. According to research of
Watson and associates, 10% of patients treated by FDs
have some sexual problems, be they physical or psycho-
logical11. A third of the grown male population in France
has some problems with sexual dysfunction, which is af-
fecting middle aged males more and more12. [tulhofer’s
research shows that 5.8% of men under the age of 39 in
Croatia suffer from sexual dysfunction, 80% of which are
physically-, and 20% psychologically-caused13. The FDs
play a big role in diagnosing the cause of dysfunction,
since they are familiar with the comorbidity of their pa-
tients and are able to guide them towards treatment
more easily.
It appears that »early« prostate cancer detection with
the PSA in the general population led to a rise in the
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Fig. 4. Morbidity trends in other males’ diseases (N41-N51) and
structure of morbidity in relation to the male’ age recorded in
family medicine in Croatia, 1995–2012.
TABLE 1
PROSTATE CANCER INCIDENCE, NUMBER AND PERCENTAGE







1995 513 411 80.1
1996 560 410 73.2
1997 610 417 68.4
1998 631 354 56.1
1999 613 444 72.4
2000 694 427 61.5
2001 935 466 49.8
2002 1128 478 42.4
2003 1218 488 40.1
2004 1353 601 44.4
2005 1247 591 47.4
2006 1507 636 42.2
2007 1529 604 39.5
2008 1583 637 40.2
2009 1691 641 37.9
2010 1783 694 38.9
2011 1786 723 40.5
number of patients, but not to a fall in mortality rates,
especially not since 2002. A great number of patients had
to visit their physicians more often, experience fear and
uncertainty, aggressive diagnostic examinations due to
false positive PSA results. Many patients also had to un-
dergo »unpleasant« treatments for prostate cancer which
would never have been discovered nor have had any
bearing on their quality of life of life expectancy14,15.
There has also been data collected on morbidity of dis-
eases of female sex organs recorded in family medicine
for the sake of comparison. While the number of male
gender disease registered in FM increased, the number of
diseases related to the female gender decreased. This can
be explained by the fact that some gynecological diseases
have been exempted from the FD’s scope of work and fall
exclusively under the domain of gynecologists.
The research results indicate that the FDs are in-
volved in the men’s health matters. Since the FD is the
only primary care physicians responsible for men’s health,
their knowledge, skill and willingness are crucial16,17.
Men’s health could be better cared for by improving the
system of recording health problems, thereby gaining a
better insight into the existing state. There is a need to
investigate the men’s personal medical records, to look at
the specific diagnoses or procedures done in the field of
men’s health. It should not be difficult because the medi-
cal records are kept in electronic form.
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ULOGA LIJE^NIKA OBITELJSKE MEDICINE U ZA[TITI ZDRAVLJA MU[KARACA: RUTINSKI
PRIKUPLJENI PODACI
S A @ E T A K
Cilj rada je bio istra`iti pokazatelje o radu lije~nika obiteljke medicine (LOM) u za{titi mu{kog zdravlja. Izvor poda-
taka su bili Hrvatsko zdravstveno-statisti~kih ljetopisi u periodu od 1995 do 2012. godine. Ukupni pobol od bolesti
urogenitalnog trakta se skoro udvostru~io, a bolesti povezane za mu{ki spol su se pove}ale ~etiri puta. Porast je zabi-
lje`en u svim dobnim skupinama. Broj dijagnoza hipertplazije prostate je porastao za 4,8 puta, najve}i rast je zabilje`en
kod mu{karaca u dobi 65 i vi{e godina (za 5,5 puta), ali je porastao i u srednjoj dobnoj skupini (za 3,8 puta).Ukupni
pobol od ostalih bolesti mu{kih spolnih organa (N41-N51) je trostruko porastao, a najvi{e u populaciji od 7–19 godina
(za 4,6 puta). Usprkos porastu incidencije karcinoma prostate, broj smrtnih slu~ajeva se ne smanjuje, nego je stabilan
od 2001. godine. Pitanje je je li ovaj progresivni rast broja zabilje`enih dijagnoza poslijedica stvarnog pogor{anja mu{-
kog zdravlja ili prekomjernog dijagnosticiranja.
M. Rapi} and M. Vrci} Keglevi}: Family Doctors and Men’s Health, Coll. Antropol. 38 (2014) Suppl. 2: 227–230
230
